Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

Obtaining approval from the U.S. Food and Drug Administration (FDA) for a key medication can be a huge catalyst for a ...

In a phase 2 study, the company's medication suzetrigine barely performed better than a placebo in treating painful ...

Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $450 from $433 and keeps a Sector Perform rating on the shares. The company had a strong Q4, with revenue beating ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vertex Pharma could be close to succeeding in the long-standing quest to find an alternative to potentially addictive opioids for the treatment of pain associated with common medical procedures.

The effect of cystic fibrosis on many organs and the frequent lung infections means that it is mostly diagnosed in childhood. Somehow, for Verônica Stasiak Bednarczuk, that diagnosis did not arrive ...

Starting things off with what arguably is the best thin and light laptop on this list. The MacBook Air 15-inch is equipped with Apple powerhouse M3 chip. The chip includes an 8-core CPU and a 10 ...

A local hunting guide in Teller County explains what message he received from Colorado Parks and Wildlife about recent wolf ...